Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer

ABSTRACT: We compared the prognostic significance of ectodomain isoforms of the epidermal growth factor receptor (EGFR), which lack the tyrosine kinase (TK) domain, with that of the full length receptor and its autophosphorylation status in cervical cancers treated with conventional chemoradiotherapy. We further explored signaling pathways that were correlated with high expression of ectodomain isoforms by gene expression analysis of 110 of the tumors, and validated the results in an independent cohort of 41 tumors. Pathways associated with the expression of ectodomain isoforms were studied by gene expression analysis with Illumina beadarrays in 110 patients and validated in an independent cohort of 41 patients.

ORGANISM(S): Homo sapiens

SUBMITTER: Heidi Lyng 

PROVIDER: E-GEOD-29817 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.

Halle Cathinka C   Lando Malin M   Svendsrud Debbie Hege DH   Clancy Trevor T   Holden Marit M   Sundfør Kolbein K   Kristensen Gunnar B GB   Holm Ruth R   Lyng Heidi H  

Clinical cancer research : an official journal of the American Association for Cancer Research 20110707 16

<h4>Purpose</h4>We compared the prognostic significance of ectodomain isoforms of the epidermal growth factor receptor (EGFR), which lack the tyrosine kinase (TK) domain, with that of the full-length receptor and its autophosphorylation status in cervical cancers treated with conventional chemoradiotherapy.<h4>Experimental design</h4>Expression of EGFR isoforms was assessed by immunohistochemistry in a prospectively collected cohort of 178 patients with squamous cell cervical carcinoma, and thei  ...[more]

Similar Datasets

Transcriptomics Drivers of gene expression in cervical cancer
2013-01-31 | E-GEOD-27469 | biostudies-arrayexpress
Transcriptomics Identification of eight candidate target genes of the prognsotic 3p loss in cervical cancer by integrative genomic profiling
2013-02-28 | E-GEOD-38964 | biostudies-arrayexpress
Transcriptomics Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast enhanced MRI
2012-08-16 | E-GEOD-36562 | biostudies-arrayexpress
Transcriptomics Integrative analysis of DCE-MRI and gene expression profiles in construction of a gene classifier for assessment of hypoxia-related risk of chemoradiotherapy failure in cervical cancer
2016-03-29 | E-GEOD-72723 | biostudies-arrayexpress
Transcriptomics Selection of reference genes for gene expression studies related to hypoxia in cervical cancer
2016-03-29 | E-GEOD-75034 | biostudies-arrayexpress
Transcriptomics Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer
2011-07-19 | GSE29817 | GEO
Transcriptomics Transcription profiling of human cervical cancer cells to identify genes that showed a correlation between expression and copy number
2009-10-12 | E-TABM-817 | biostudies-arrayexpress
Transcriptomics Transcription profiling of node positive and negative human cervical tumor
2006-10-23 | E-TABM-146 | biostudies-arrayexpress
Transcriptomics Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
2015-09-14 | E-GEOD-68339 | biostudies-arrayexpress
Proteomics Phosphoproteomics scaled-down to tumor biopsy level. Part 2: biopsies
2019-10-28 | PXD003814 | Pride